OTCPK:JWCTF (China)
Â
Ordinary Shares
$
0.17
-0.01942 (-10.17%)
11:09 PM EST
Business Description
JW (Cayman) Therapeutics Co Ltd
ISIN : KYG5210T1040
Share Class Description:
JWCTF: Ordinary SharesCompare
Compare
Traded in other countries / regions
02126.Hong KongJWCTF.USAJNY.Germany IPO Date
2021-02-26Description
JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.16 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -0.87 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -3.26 | |||||
Beneish M-Score | -3.78 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 50.9 | |||||
3-Year EPS without NRI Growth Rate | 52.6 | |||||
3-Year FCF Growth Rate | 32.6 | |||||
3-Year Book Growth Rate | -24.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 12.99 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 56.41 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 0.03 | |||||
14-Day RSI | 0.72 | |||||
6-1 Month Momentum % | -14.27 | |||||
12-1 Month Momentum % | -25.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.04 | |||||
Quick Ratio | 3.9 | |||||
Cash Ratio | 3.8 | |||||
Days Inventory | 331.15 | |||||
Days Sales Outstanding | 22.53 | |||||
Days Payable | 50.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.1 | |||||
Shareholder Yield % | -28.08 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.08 | |||||
Operating Margin % | -351.89 | |||||
Net Margin % | -433.57 | |||||
FCF Margin % | -279.13 | |||||
ROE % | -18.32 | |||||
ROA % | -14.92 | |||||
ROIC % | -21.18 | |||||
3-Year ROIIC % | 45.86 | |||||
ROC (Joel Greenblatt) % | -100.7 | |||||
ROCE % | -16.74 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.78 | |||||
PB Ratio | 0.25 | |||||
Price-to-Tangible-Book | 0.44 | |||||
EV-to-EBIT | 0.53 | |||||
EV-to-EBITDA | 0.54 | |||||
EV-to-Revenue | -2.28 | |||||
EV-to-FCF | 0.84 | |||||
Price-to-Net-Current-Asset-Value | 0.69 | |||||
Price-to-Net-Cash | 0.78 | |||||
Earnings Yield (Greenblatt) % | 188.68 | |||||
FCF Yield % | -55.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:JWCTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JW (Cayman) Therapeutics Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 12.252 | ||
EPS (TTM) ($) | -0.212 | ||
Beta | 1.99 | ||
Volatility % | 93.39 | ||
14-Day RSI | 0.72 | ||
14-Day ATR ($) | 0.002582 | ||
20-Day SMA ($) | 0.195064 | ||
12-1 Month Momentum % | -25.9 | ||
52-Week Range ($) | 0.17158 - 0.41 | ||
Shares Outstanding (Mil) | 414.36 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
JW (Cayman) Therapeutics Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
JW (Cayman) Therapeutics Co Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
JW (Cayman) Therapeutics Co Ltd Frequently Asked Questions
What is JW (Cayman) Therapeutics Co Ltd(JWCTF)'s stock price today?
The current price of JWCTF is $0.17. The 52 week high of JWCTF is $0.41 and 52 week low is $0.17.
When is next earnings date of JW (Cayman) Therapeutics Co Ltd(JWCTF)?
The next earnings date of JW (Cayman) Therapeutics Co Ltd(JWCTF) is .
Does JW (Cayman) Therapeutics Co Ltd(JWCTF) pay dividends? If so, how much?
JW (Cayman) Therapeutics Co Ltd(JWCTF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |